DV
Dividend Vision

BIO — Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc. (BIO)

Its deepest 1-year drawdown was 28.9%.

Bio-Rad Laboratories, Inc. is an equity stock that operates in the life sciences and clinical diagnostics sector, focusing on the development and manufacturing of products for research and healthcare applications. The stock does not currently maintain a dividend distribution program, making it oriented toward capital appreciation rather than income generation. This holding appeals primarily to growth-oriented investors seeking exposure to the biotechnology and diagnostics industry rather than those prioritizing regular dividend income.

BIO key facts

Asset type
Stock
Asset class
Equity
Inception date
02/27/1980
Distribution frequency
None
Last close
$356.26
Market cap
$9,525,742,592
Average volume
173800.0
Beta
1.047
Payout ratio
0.0
P/E ratio
43.4463
Forward P/E
38.9105
EPS
$8.20